Be the first to reviewOnly 4 left!
{{ header }}
{% include 'pharma/css/product-css.twig' %}
{% include 'default/template/common/zoom_image.twig' with {'image':image} %}
{{ content_bottom }}
{% include 'default/template/common/product_schema.twig' %}
{% if config_live_price==1 %}
{% endif %}
{% include 'default/asset/js/product-js.twig' %}
{{ footer }}
{{ column_left }}
{% if column_left and column_right %}
{% set class = 'col-sm-6' %}
{% elseif column_left or column_right %}
{% set class = 'col-sm-9' %}
{% else %}
{% set class = 'col-sm-12' %}
{% endif %}
{{ column_right }}
{{ content_top }}
{% set class = 'col-sm-12 col-md-12 col-lg-7 col-xl-7' %}
{% include 'default/template/product/product_image.twig' %}
{% set class = 'col-sm-12 col-md-12 col-lg-5 col xl-5' %}
{% if review_status %}
{% endif %}
{% if config_offer_coupons and offer_coupons_count >=1%}
{% include 'default/template/product/offer.twig' with {'offer_coupons':offer_coupons } %}
{% endif %}
{% if tags %}
{% if rating %}
Rating
{% endif %}
{% if rating %}
•
{% else %}
{% endif %}
{{ reviews }}
{% endif %}
{{ reviews }}
{% include 'default/template/common/wishlist.twig' with {'is_wishlist': is_wishlist} %}
{% include 'default/template/common/socialbootstrap.twig' with {'product_url': product_url, 'heading_title': heading_title } %}
{% if attribute_groups %}
{% for attribute_group in attribute_groups %}
{% else %}
{% endif %}
| {{ attribute_group.name }} | |
| {{ attribute.name }} | {{ attribute.text }} |
No specifications available.
{{ tab_description }}
{{ description }}
{% if review_status %}
{{ tab_review }}
{% include 'default/template/common/review_form.twig' %}
{% endif %}
{{ text_tags }}
{% for i in 0..tags|length %}
{% if i < (tags|length - 1) %} {{ tags[i].tag }},
{% else %} {{ tags[i].tag }} {% endif %}
{% endfor %}
{% endif %}
No specifications available.
Description
C E F P O D O X I M E 100 mg + Clavulanate 62.5 mg | Dry Syrup
Ideal switch-over
from IV Ceftriaxone in serious RTI.
Ensures high efficacy
in tough infections.
Extended spectrum
of cefpodoxime against beta-lactamase strains.
INDICATIONS
Urinary Tract
Infections
Infections
Asthma
Airway Disease
Nasal Allergies
Reviews (0)
